HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 7 of 7
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleHarada, Kazuaki; Yamamura, Takahiro; Muto, Osamu; Nakamura, Michio; Sogabe, Susumu; Sawada, Kentaro; Nakano, Shintaro; Yagisawa, Masataka; Muranaka, Tetsuhito; Dazai, Masayoshi; Tateyama, Miki; Kobayashi, Yoshimitsu; Kato, Sosuke; Hatanaka, Kazuteru; Kawamoto, Yasuyuki; Yuki, Satoshi; Sakata, Yuh; Sakamoto, Naoya; Komatsu, YoshitoCorrelation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma : A Multicenter, Retrospective Cohort Study (HGCSG2101)-Journal of clinical medicine-Feb-2023
articleNakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, YuStudy protocol for HGCSG1801 : A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies-Frontiers in oncology-9-Nov-2022
articleKen, Ito; Satoshi, Yuki; Hiroshi, Nakatsumi; Kawamoto, Yasuyuki; Harada, Kazuaki; Nakano, Shintaro; Saito, Rika; Ando, Takayuki; Sawada, Kentaro; Yagisawa, Masataka; Ishiguro, Atsushi; Dazai, Masayoshi; Iwanaga, Ichiro; Hatanaka, Kazuteru; Sato, Atsushi; Matsumoto, Ryusuke; Shindo, Yoshiaki; Tateyama, Miki; Muranaka, Tetsuhito; Katagiri, Masaki; Yokota, Isao; Sakata, Yuh; Sakamoto, Naoya; Komatsu, YoshitoMulticenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer-Supportive Care in Cancer-1-Jun-2022
articleNakano, Shintaro; Kawamoto, Yasuyuki; Yuki, Satoshi; Harada, Kazuaki; Miyagishima, Takuto; Sogabe, Susumu; Dazai, Masayoshi; Sato, Atsushi; Ishiguro, Atsushi; Nakamura, Michio; Kajiura, Shinya; Takahashi, Yasuo; Tateyama, Miki; Hatanaka, Kazuteru; Tsuji, Yasushi; Sasaki, Takahide; Shindo, Yoshiaki; Kobayashi, Tomoe; Yokota, Isao; Sakamoto, Naoya; Sakata, Yuh; Komatsu, YoshitoStudy protocol of the HGCSG1803 : a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer-BMJ Open-May-2022
article (author version)Suda, Goki; Kudo, Mineo; Nagasaka, Atsushi; Furuya, Ken; Yamamoto, Yoshiya; Kobayashi, Tomoe; Shinada, Keisuke; Tateyama, Miki; Konno, Jun; Tsukuda, Yoko; Yamasaki, Kazushi; Kimura, Megumi; Umemura, Machiko; Izumi, Takaaki; Tsunematsu, Seiji; Sato, Fumiyuki; Terashita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaEfficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C-Journal of gastroenterology-Jul-2016
articleKomatsu, Yoshito; Okita, Kenji; Yuki, Satoshi; Furuhata, Tomohisa; Fukushima, Hiraku; Masuko, Hiroyuki; Kawamoto, Yasuyuki; Isobe, Hiroshi; Miyagishima, Takuto; Sasaki, Kazuaki; Nakamura, Michio; Ohsaki, Yoshinobu; Nakajima, Junta; Tateyama, Miki; Eto, Kazunori; Minami, Shinya; Yokoyama, Ryoji; Iwanaga, Ichiro; Shibuya, Hitoshi; Kudo, Mineo; Oba, Koji; Takahashi, YasuoOpen-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron-Cancer science-Jul-2015
article (author version)Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, Hiroshi; Kobayashi, Yoshimitsu; Iwanaga, Ichiro; Nakamura, Michio; Hatanaka, Kazuteru; Miyagishima, Takuto; Kudo, Mineo; Munakata, Masaki; Meguro, Takashi; Tateyama, Miki; Sakata, YuhPhase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer-Acta Oncologica-Sep-2012
Showing results 1 to 7 of 7

 

Hokkaido University